{"id":17418,"date":"2020-02-21T11:01:14","date_gmt":"2020-02-21T10:01:14","guid":{"rendered":"http:\/\/k2info.w.uib.no\/?p=17418"},"modified":"2020-02-21T11:01:14","modified_gmt":"2020-02-21T10:01:14","slug":"hvad-nuh-nar-soknaden-din-blir-avvist","status":"publish","type":"post","link":"https:\/\/k2info.w.uib.no\/en\/2020\/02\/21\/hvad-nuh-nar-soknaden-din-blir-avvist\/","title":{"rendered":"[:no]Hvad nuh, n\u00e5r s\u00f8knaden din blir avvist?[:en]What to do when your grant application is rejected[:]"},"content":{"rendered":"<p>[:no]<a href=\"http:\/\/k2info.w.uib.no\/files\/2018\/08\/P\u00e5l-Nj\u00f8lstad.png\"><img loading=\"lazy\" decoding=\"async\" class=\" wp-image-14369 alignleft\" src=\"http:\/\/k2info.w.uib.no\/files\/2018\/08\/P\u00e5l-Nj\u00f8lstad.png\" alt=\"\" width=\"135\" height=\"177\" srcset=\"https:\/\/k2info.w.uib.no\/files\/2018\/08\/P\u00e5l-Nj\u00f8lstad.png 250w, https:\/\/k2info.w.uib.no\/files\/2018\/08\/P\u00e5l-Nj\u00f8lstad-229x300.png 229w\" sizes=\"auto, (max-width: 135px) 100vw, 135px\" \/><\/a>Etter en vind- og regnfull vinter n\u00e6rmer det seg frister for 2020-s\u00f8knadene. I tilknytning til dette skrev James Mitchell Crow nettopp en interessant kommentar (Nature 578, 477-479) om hva du gj\u00f8r n\u00e5r s\u00f8knaden din om forskningsmidler blir avvist. For for de fleste s\u00f8kere er avslag regelen og ikke unntaket. Avslag kan inneb\u00e6re en berg-og-dalbane-opplevelse med sinne, skuffelse, fortvilelse og sorg. Gi deg selv tid til \u00e5 ford\u00f8ye responsen, og kom f\u00f8rst tilbake til s\u00f8knaden n\u00e5r du har et klart mind set til \u00e5 gj\u00f8re det konstruktivt.<\/p>\n<p>Ved National Institutes of Health i USA var den samlede suksessraten for forskning p\u00e5 forskningsstipendier 20,5% i 2017. Suksessraten er lignende i Novo Nordisk Fonden. Hos Wellcome i Storbritannia klarte rundt 50% av s\u00f8knadene i 2017-18 \u00e5 passere f\u00f8rste stadiet. Av disse ble rundt 20% finansiert. I det f\u00f8rst delen av H2020-programmet var suksessraten bare 14%, og hos Norges forskningsr\u00e5d er den dessverre enda lavere; rundt 5-10% for de \u00e5pne utlysningenea. En god ide er derfor ingen garanti for suksess, og veldig gode s\u00f8knader blir avvist p\u00e5 grunn av manglende finansiering.<\/p>\n<p>S\u00e5, hva gj\u00f8r du?<\/p>\n<p>Det viktigste er at du aldri gir opp. For hver gang du skriver en s\u00f8knad om midler, forbedres den litt, og plutselig er du over terskelen og \/ eller en ny vurderer liker s\u00f8knaden.<\/p>\n<p>Kan du f\u00e5 submittert sentrale manuskripter for ideen bak s\u00f8knaden? Kan du samle inn og presentere forel\u00f8pige data og \/ eller kj\u00f8re en pilotstudie? Disse punktene kan v\u00e6re viktige for \u00e5 tilfredsstille anmelderne n\u00e5r det gjelder gjennomf\u00f8ringsevne som viktig evalueringskriterium.<\/p>\n<p>\u00c5 etablere nye samarbeid, kan forbedre s\u00f8knaden ved at andre kritisk vurderer forskningen din. Det kan ogs\u00e5 forbedre nettverket og renomm\u00e9 som PI.<\/p>\n<p>Hvis du diskuterer avslaget med dine kolleger, mentorer og andre, kan du f\u00e5 emosjonell st\u00f8tte p\u00e5 kort sikt og konstruktive tilbakemeldinger for \u00e5 hjelpe deg med \u00e5 s\u00f8ke om til neste runde.<\/p>\n<p>N\u00e5r du har tilbakemeldinger fra anmelderne, er det viktig \u00e5 im\u00f8tekomme deres innvendinger. Det er lite sannsynlig at de samme anmelderne vil evaluere s\u00f8knaden din en gang til, s\u00e5 arbeid uansett gjennom alle aspekter av s\u00f8knaden for neste runde.<\/p>\n<p>Som oftest blir ikke s\u00f8knaden din lest av en ekspert p\u00e5 ditt felt. Derfor kan det v\u00e6re nyttig \u00e5 dele den reviderte s\u00f8knaden med forskere som ikke er eksperter p\u00e5 ditt felt. Kan din bedre halvdel forst\u00e5 sammendrag og hovedm\u00e5lene dine? Hvis ikke, b\u00f8r du vurdere \u00e5 skrive om. Et poeng kan aldri formidles for enkelt. Tenk p\u00e5 s\u00f8knaden din som en historie du vil fortelle. Gj\u00f8r reisen s\u00e5 spennende, at anmelderne vil lese mer.<\/p>\n<p>Lykke til med \u00e5 forberede s\u00f8knadene for 2020. Men f\u00f8r det, kan vi glede oss over vinterferien!<\/p>\n<p>P\u00e5l[:en]<a href=\"http:\/\/k2info.w.uib.no\/files\/2018\/08\/P\u00e5l-Nj\u00f8lstad.png\"><img loading=\"lazy\" decoding=\"async\" class=\" wp-image-14369 alignleft\" src=\"http:\/\/k2info.w.uib.no\/files\/2018\/08\/P\u00e5l-Nj\u00f8lstad.png\" alt=\"\" width=\"135\" height=\"177\" srcset=\"https:\/\/k2info.w.uib.no\/files\/2018\/08\/P\u00e5l-Nj\u00f8lstad.png 250w, https:\/\/k2info.w.uib.no\/files\/2018\/08\/P\u00e5l-Nj\u00f8lstad-229x300.png 229w\" sizes=\"auto, (max-width: 135px) 100vw, 135px\" \/><\/a>After a windy and rainy winter, deadlines for the 2020 applications are approaching. Related to this, James Mitchell Crow just wrote an interesting commentary (<em>Nature<\/em>\u00a0578, 477-479) on what do to when your grant is rejected. Because for most applicants, rejection is the rule and not the exception. Rejection can be a rollercoaster experience with anger, disappointment, despair, and grief. Give yourself time to digest the response, and only then get back to the application when you have a clear mind to do it constructively.<\/p>\n<p>At the National Institutes of Health in the US, the 2017 aggregate success rate for research grants was 20.5%. The success rate is similar in Novo Nordisk Fonden. At Wellcome in the UK, around 50% of applications 2017-18 made it through the preliminary stage. Of those, around 20% were funded. In the initial H2020 programme, the success rate was only 14%, and at the Research Council of Norway, it is unfortunately even lower; around 5-10% in the open calls. Hence, a good idea is no guarantee of grant success, and very good applications are rejected due to lack of funding.<\/p>\n<p>So, what to do?<\/p>\n<p>Most importantly, never give up. For each time you write a grant application, it improves a little and suddenly you are over the threshold and\/or a new reviewer likes the application.<\/p>\n<p>Can you get key manuscripts for the idea submitted? Can you collect and present preliminary data and\/or run a pilot study? These points may be important to satisfy reviewers regarding the key evaluation criterion feasibility.<\/p>\n<p>To establish new collaborations can improve your science by other people scrutinizing your research. Also, that can improve your network and track as a PI.<\/p>\n<p>If you discuss the grant rejection with your colleagues, mentors and others, you might get emotional support in the short term, and constructive feedback to help reapply for the grant at the next round.<\/p>\n<p>When you have feedback from the reviewers, it is vital to address the concerns of these. Still, it is unlikely that the same reviewers will evaluate your application once more, so work through all aspects of the application for the next round.<\/p>\n<p>Most often, your application was not read by an expert in your field. Therefore, it may be helpful to share the revision to scientists who are not experts in your field. Can your spouse understand your abstract and main outline? If not, you should try to rewrite. A message can never be too simple. And think of your application as a story you want to tell and make that journey exciting so the reviewers want to read more.<\/p>\n<p>Good luck preparing your grant applications for 2020. But before that, enjoy the winter holidays!<\/p>\n<p>P\u00e5l[:]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>[:no]Etter en vind- og regnfull vinter n\u00e6rmer det seg frister for 2020-s\u00f8knadene. I tilknytning til dette skrev James Mitchell Crow nettopp en interessant kommentar (Nature 578, 477-479) om hva du gj\u00f8r n\u00e5r s\u00f8knaden din om forskningsmidler blir avvist. For for&hellip;<\/p>\n<p class=\"more-link-p\"><a class=\"more-link\" href=\"https:\/\/k2info.w.uib.no\/en\/2020\/02\/21\/hvad-nuh-nar-soknaden-din-blir-avvist\/\">Read more &rarr;<\/a><\/p>\n","protected":false},"author":4575,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[39969],"tags":[],"class_list":["post-17418","post","type-post","status-publish","format-standard","hentry","category-ukens-leder"],"_links":{"self":[{"href":"https:\/\/k2info.w.uib.no\/en\/wp-json\/wp\/v2\/posts\/17418","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/k2info.w.uib.no\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/k2info.w.uib.no\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/k2info.w.uib.no\/en\/wp-json\/wp\/v2\/users\/4575"}],"replies":[{"embeddable":true,"href":"https:\/\/k2info.w.uib.no\/en\/wp-json\/wp\/v2\/comments?post=17418"}],"version-history":[{"count":1,"href":"https:\/\/k2info.w.uib.no\/en\/wp-json\/wp\/v2\/posts\/17418\/revisions"}],"predecessor-version":[{"id":17419,"href":"https:\/\/k2info.w.uib.no\/en\/wp-json\/wp\/v2\/posts\/17418\/revisions\/17419"}],"wp:attachment":[{"href":"https:\/\/k2info.w.uib.no\/en\/wp-json\/wp\/v2\/media?parent=17418"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/k2info.w.uib.no\/en\/wp-json\/wp\/v2\/categories?post=17418"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/k2info.w.uib.no\/en\/wp-json\/wp\/v2\/tags?post=17418"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}